Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/1999
11/16/1999CA2010272C Benzenesulfonamides and a process for their preparation
11/11/1999WO1999057288A1 Endothelin-converting-enzyme like protein
11/11/1999WO1999057153A1 Heparanase specific molecular probes and their use in research and medical applications
11/11/1999WO1999057149A2 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/11/1999WO1999057114A1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
11/11/1999WO1999057101A1 Pyrazole derivatives as p-38 map kinase inhibitors
11/11/1999WO1999056781A1 Methods of using isomer enriched conjugated linoleic acid compositions
11/11/1999WO1999056780A1 Isomer enriched conjugated linoleic acid compositions
11/11/1999WO1999056768A1 Methods for treating diabetes by inhibiting gdf-8
11/11/1999WO1999056763A1 Use of neglected target tissue antigens in modulation of immune responses
11/11/1999WO1999056758A1 A food composition and method of using same
11/11/1999WO1999056737A1 Arylhydrocarbon receptor ligand antagonists
11/11/1999WO1999056558A1 Phytosterol compositions
11/11/1999WO1999045016A9 Novel prodrugs for phosphorus-containing compounds
11/11/1999WO1998004528A3 Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents
11/11/1999CA2331364A1 Arylhydrocarbon receptor ligand antagonists
11/11/1999CA2329065A1 Pyrazole derivatives as p-38 map kinase inhibitors
11/11/1999CA2328108A1 Use of neglected target tissue antigens in modulation of immune responses
11/11/1999CA2327530A1 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/11/1999CA2295323A1 Heparanase specific molecular probes and their use in research and medical applications
11/11/1999CA2248963A1 Novel compounds
11/10/1999EP0955314A2 Peptide analogues of glucagon-like-peptide-1 (7-37), their preparation and pharmaceutical compositions
11/10/1999EP0955301A2 7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylchloline receptors
11/10/1999EP0955044A2 Method of inhibiting bacterial or fungal growth using a complexing agent
11/10/1999EP0954983A2 Methods of using isomer enriched conjugated linoleic acid compositions
11/10/1999EP0954975A2 Isomer enriched conjugated linoleic acid compositions
11/10/1999EP0954588A1 Ob fusion protein compositions and methods
11/10/1999EP0954587A1 Expression in yeast of antigenically active, recombinant hybrid glutamic acid decarboxylase
11/10/1999EP0954565A1 Adipogenic differentiation of human mesenchymal stem cells
11/10/1999EP0954535A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use
11/10/1999EP0954519A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
11/10/1999EP0954324A1 Cyclic peptide vaccines for treatment and prevention of diabetes
11/10/1999EP0954317A2 Use of 7 apha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
11/10/1999EP0954308A1 Therapeutic treatment for cardiovascular diseases
11/10/1999EP0954306A1 Methods of increasing nitric oxide synthesis
11/10/1999EP0954297A1 Use of bisphenolic compounds to treat type ii diabetes
11/10/1999EP0954282A1 Preparation of particles for inhalation
11/10/1999CN1234799A 1,4-disubstituted piperazines
11/10/1999CN1234797A N-substituted azaheterocyclic compound
11/10/1999CN1234396A Process for alkylation of hindered sulfamide
11/10/1999CN1234270A Pancreas-recovering thirst-relieving and blood-sugar reducing powder, and preparing method thereof
11/09/1999US5981821 Dressing product with a calcium alginate matrix and method of production of the same
11/09/1999US5981780 In vivo calcium transport as well as bone calcium mobilization activity, treatment of osteoporosis, possible use in the treatment of cancerous diseases
11/09/1999US5981762 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors
11/09/1999US5981693 Process for removing bile salts from a patient and alkylated compositions therefor
11/09/1999US5981599 Inorganic ion receptor active compounds
11/09/1999US5981579 Use of nitrovasodilators for treatment of disease or stress conditions in a non-human mammal
11/09/1999US5981570 Benzothiophene compounds, compositions, and methods
11/09/1999US5981539 Piperidine compounds as calcium channel blockers
11/09/1999US5981527 Cyclic GMP-specific phosphodiesterase inhibitors
11/09/1999US5981525 Indole derivatives useful in the treatment of osteoporosis
11/09/1999US5981494 Administering to the mammal a glycosidase inhibitor to inhibit the conversion of pro-toxin to toxin which causes maleria, endotoxic shock or septic shock in mammals
11/09/1999US5981491 Peptides; metalloenzymes; tumor necrosis factor
11/09/1999US5981488 Polypeptide; antidiabetic agent
11/09/1999US5981483 Compositions comprising modulators of cytokines of the TGF-β superfamily
11/09/1999US5980905 Supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass; in combination with at least one of a cyclooxygenase inhibitor, an acid, a mucolytic and a salicin-containing herb
11/09/1999US5980902 Compositions for treating and preventing diabetes, impaired glucose tolerance and related symptoms, and methods for preparing and using such compositions
11/09/1999US5980887 Methods for enhancing angiogenesis with endothelial progenitor cells
11/09/1999CA2177780C New arylalkyl(thio)carboxamide compounds, their preparation processes and the pharmaceutical compositions that contain them
11/04/1999WO1999055893A1 Retroviral vectors including modified envelope escort proteins
11/04/1999WO1999055734A1 A g-protein coupled 7tm receptor (axor-1)
11/04/1999WO1999055733A1 Cloning of a novel 7tm receptor axor-2
11/04/1999WO1999055713A1 Phosphonic diester derivatives
11/04/1999WO1999055699A1 Paroxetine 10-camphorsulfonate for treatment of cns disorders
11/04/1999WO1999055680A1 Aryl fused azapolycyclic compounds
11/04/1999WO1999055678A1 Quinoline derivatives
11/04/1999WO1999055667A1 N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
11/04/1999WO1999055371A1 Solution containing nicotine
11/04/1999WO1999055351A1 Herbal composition and medicament against diabetes mellitus type ii manufactured thereof
11/04/1999WO1999055331A1 Use of alpha lipoic acid to reduce appetite and/or body weight
11/04/1999WO1999055321A1 Compounds and methods for treating mitochondria-associated diseases
11/04/1999WO1999055313A1 Pellets having a core coated with a lipid lowering agent and a polymer
11/04/1999CA2367888A1 Herbal composition and medicament against diabetes mellitus type ii manufactured thereof
11/04/1999CA2330644A1 Solution containing nicotine
11/04/1999CA2330576A1 Substituted benzazocines as nicotine-binding inhibitors
11/04/1999CA2330111A1 Phosphonic acid diester derivatives and their use in lowering blood glucose level and treating diabetes
11/04/1999CA2329913A1 Paroxetine 10-camphorsulfonate for treatment of cns disorders
11/04/1999CA2329709A1 Compounds and methods for treating mitochondria-associated diseases
11/04/1999CA2328970A1 Pellets having a core coated with a lipid lowering agent and a polymer
11/03/1999EP0953636A2 Cytokine signal regulators
11/03/1999EP0952837A1 Use of mixtures of active substances, containing phytostenols and/or phytostenol esters and potentiators, for the production of hypocholesteremic agents
11/03/1999EP0952830A1 Use of raloxifene and of related compounds for the manufacture of a medicament for lowering plasma levels of lipoprotein(a)
11/03/1999EP0952829A1 Pharmaceutical composition of fenofibrate with high biological availability and method for preparing same
11/03/1999EP0894083B1 Creatine pyruvates and method for their production
11/03/1999CN1234118A Material and method relating to diagnosis and treatment of diabetes and obesity
11/03/1999CN1234071A Keratinocyte grouth factor -2(KGF-2 or fibroblast growth factor-12, FGF-12)
11/03/1999CN1234031A Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the prodn. of tumor necrosis factor (TNF)
11/03/1999CN1233468A Pharmaceutical composition comprising bisphosphonic acid
11/02/1999US5977382 Benzo[b]thiophene compounds, intermediates, processes, compositions, and methods
11/02/1999US5977374 5-(4-hydroxy-OR 4-acetoxy-benzyl)-3- triphenylmethylthiazolidine-2,4-dione and method for producing same
11/02/1999US5977365 Heterocyclic compound having anti-diabetic activity
11/02/1999US5977178 Compounds with growth hormone releasing properties
11/02/1999US5977157 Methods for inhibiting endometriosis
11/02/1999US5977155 Cardiovascular, kidneys
11/02/1999US5977154 Obesity, diabetes
11/02/1999US5977131 Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents
11/02/1999US5977124 β-adrenergic agonists
11/02/1999US5977121 Use of moxonidine for the treatment of atherosclerosis
11/02/1999US5977107 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists
11/02/1999US5977103 Substituted imidazole compounds
1 ... 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 ... 1298